Skip to main content
Year archive

Genscript Biotech Corporation — 2024 filings

All 103 regulatory filings released by Genscript Biotech Corporation (1548) in 2024, sourced directly from the official regulator.

103 Filings
2024 Period
2024 filings (103)
Filing Released Lang
Next Day Disclosure Return
Transaction in Own Shares
2024-12-31 English
COMPANY EXERCISES THE CONVERSION RIGHTS OF THE CONVERTIBLE BOND ISSUED BY PROBIO CAYMAN
Share Issue/Capital Change
2024-12-20 English
Next Day Disclosure Return
Transaction in Own Shares
2024-12-10 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTCH ANNOUNCES PRESENTATIONS AT THE 2024 ASH ANNUAL MEETING
Regulatory Filings
2024-12-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
Regulatory Filings
2024-12-03 English
Next Day Disclosure Return
Share Issue/Capital Change
2024-12-02 English
RESIGNATION OF ROTATING CHIEF EXECUTIVE OFFICER
Board/Management Information
2024-12-02 English
Next Day Disclosure Return
Regulatory Filings
2024-11-21 English
Next Day Disclosure Return
Regulatory Filings
2024-11-20 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2024-11-19 English
Next Day Disclosure Return
Regulatory Filings
2024-11-19 English
Next Day Disclosure Return
Regulatory Filings
2024-11-18 English
INSIDE INFORMATION ANNOUNCEMENT - ENTERED INTO A LICENSE AGREEMENT BETWEEN PROBIO NANJING AND LANOVA MEDICINES LTD.
Regulatory Filings
2024-11-15 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2024-11-15 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF STRATEGY COMMITTEE
Regulatory Filings
2024-11-15 English
INSIDE INFORMATION: UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2024 OF A LISTED ASSOCIATE - LEGEND BIOTECH CORPORATION
Regulatory Filings
2024-11-12 English
Next Day Disclosure Return
Regulatory Filings
2024-11-11 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2024-11-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
Regulatory Filings
2024-11-04 English
INSIDE INFORMATION - VARIATION OF THE DEPOSIT AGREEMENT RESULTING IN DECONSOLIDATION OF LEGEND BIOTECH CORPORATION AND ITS SUBSIDIARIES
Regulatory Filings
2024-10-22 English
Overseas Regulatory Announcement: Legend Biotech Announces Results of Annual General Meeting
Regulatory Filings
2024-10-22 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED SEPTEMBER 30, 2024
Regulatory Filings
2024-10-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
Regulatory Filings
2024-10-04 English
OVERSEAS REGULATORY ANNOUNCEMENT - LATE-BREAKING LONG-TERM OVERALL SURVIVAL DATA FROM CARTITUDE-4 STUDY IN MULTIPLE MYELOMA
Regulatory Filings
2024-09-29 English
OVERSEAS REGULATORY ANNOUNCEMENT - NOTICE OF ANNUAL GENERAL MEETING OF LEGEND BIOTECH CORPORATION
Regulatory Filings
2024-09-20 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2024-09-12 English
APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Regulatory Filings
2024-09-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
Regulatory Filings
2024-09-04 English
INTERIM REPORT 2024
Regulatory Filings
2024-08-29 English
VOLUNTARY ANNOUNCEMENT-RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2024-08-27 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2024-08-19 English
Next Day Disclosure Return
Regulatory Filings
2024-08-13 English
ANNOUNCEMENT OF UNAUDITED CONSOLIDATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024
Regulatory Filings
2024-08-09 English
OVERSEAS REGULATORY ANNOUNCEMENT - FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30 JUNE 2024 AND BUSINESS HIGHLIGHTS OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2024-08-09 English
OVERSEAS REGULATORY ANNOUNCEMENT - LEGEND BIOTECH ANNOUNCES NEW APPOINTMENT TO THE BOARD OF DIRECTORS
Regulatory Filings
2024-08-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
Regulatory Filings
2024-08-06 English
(REVISED) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
Regulatory Filings
2024-08-06 English
DATE OF BOARD MEETING
Regulatory Filings
2024-07-30 English
PROFIT ALERT - ESTIMATED REDUCTION IN LOSS
Regulatory Filings
2024-07-26 English
OVERSEAS REGULATORY ANNOUNCEMENT - PRELIMINARY RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2024-07-26 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 30 JUNE 2024
Regulatory Filings
2024-07-17 English
VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
Regulatory Filings
2024-07-15 English
CLARIFICATION ANNOUNCEMENT IN RELATION TO GRANT OF RESTRICTED SHARES
Regulatory Filings
2024-07-09 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2024-07-08 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Regulatory Filings
2024-07-05 English
RESIGNATION OF DIRECTORS AND CHANGE IN COMPOSITION OF STRATEGY COMMITTEE
Regulatory Filings
2024-07-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
Regulatory Filings
2024-07-05 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES POSITIVE OVERALL SURVIVAL RESULTS OF LANDMARK PHASE 3 CARTITUDE-4 TRIAL IN MULTIPLE MYELOMA
Regulatory Filings
2024-07-02 English
INSIDE INFORMATION - RECEIVING MILESTONE PAYMENT UNDER THE COLLABORATION AGREEMENT
Regulatory Filings
2024-06-28 English
FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings
2024-06-24 English
Risk Management and ESG Committee - Terms of Reference
Regulatory Filings
2024-06-23 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2024-06-23 English
(1) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 21 JUNE 2024&#x3b; (2) RESIGNATION OF DIRECTORS&#x3b; (3) CHANGE IN COMPOSITION OF BOARD COMMITTEES&#x3b; AND (4) AMENDMENTS TO MEMORANDUM AND ARTICL
Regulatory Filings
2024-06-23 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2024-06-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
Regulatory Filings
2024-06-05 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH SHARES DATA ON THE EARLIEST USE TO DATE OF CARVYKTI IN THE TREATMENT OF MULTIPLE MYELOMA AND IMPORTANT SUBGROUP ANALYSES AT 2024 ASCO ANNUAL MEETING AN
Regulatory Filings
2024-06-04 English
Inside Information
Regulatory Filings
2024-06-02 English
SECOND FORM OF PROXY FOR THE POSTPONED 2024 ANNUAL GENERAL MEETING TO BE HELD ON 21 JUNE 2024 (OR AT ANY ADJOURNMENT THEREOF)
Regulatory Filings
2024-05-30 English
SUPPLEMENTAL NOTICE OF THE POSTPONED ANNUAL GENERAL MEETING
Regulatory Filings
2024-05-30 English
SUPPLEMENTAL CIRCULAR - RE-ELECTION OF A NON-EXECUTIVE DIRECTOR AND SUPPLEMENTAL NOTICE OF THE POSTPONED ANNUAL GENERAL MEETING
Regulatory Filings
2024-05-30 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH WILL PRESENT NEW AND UPDATED DATA ON CARVYKTI FOR PATIENTS WITH MULTIPLE MYELOMA AT 2024 ASCO AND EHA ANNUAL MEETINGS
Regulatory Filings
2024-05-24 English
Next Day Disclosure Return
Regulatory Filings
2024-05-22 English
(1) POSTPONEMENT OF ANNUAL GENERAL MEETING, (2) CHANGE OF DATES FOR CLOSURE OF REGISTER OF MEMBERS AND (3) DESPATCH OF SUPPLEMENTAL CIRCULAR, SUPPLEMENTAL NOTICE AND REVISED FORM OF PROXY
Regulatory Filings
2024-05-16 English
OVERSEAS REGULATORY ANNOUNCEMENT: UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 31 MARCH 2024 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2024-05-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Regulatory Filings
2024-05-06 English
2021 Restricted Share Award Scheme
Regulatory Filings
2024-04-24 English
2019 Restricted Share Award Scheme
Regulatory Filings
2024-04-24 English
Share Option Scheme
Regulatory Filings
2024-04-24 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH CORPORATION ANNOUNCES THE EUROPEAN COMMISSION'S APPROVAL OF CARVYKTI FOR SECOND-LINE TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE M
Regulatory Filings
2024-04-23 English
FORM OF PROXY FOR 2024 ANNUAL GENERAL MEETING
Regulatory Filings
2024-04-22 English
PROPOSALS FOR (1) GRANTING OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES, (2) RE-ELECTION OF RETIRING DIRECTORS, (3) AMENDMENT OF THE SHARE OPTION SCHEME, (4) AMENDMENT OF THE 2019
Regulatory Filings
2024-04-22 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2024-04-22 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023
Regulatory Filings
2024-04-22 English
ANNUAL REPORT 2023
Regulatory Filings
2024-04-22 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH CORPORATION ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 31 MARCH 2024
Regulatory Filings
2024-04-16 English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES AND ADOPTION OF THE AMENDED MEMORANDUM AND ARTICLES
Regulatory Filings
2024-04-12 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2024-04-12 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE IN COMPOSITION OF BOARD COMMITTEE
Regulatory Filings
2024-04-12 English
Nomination Committee -Terms of Reference
Regulatory Filings
2024-04-12 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES THE U.S. FDA'S APPROVAL OF CARVYKTI FOR SECOND-LINE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Regulatory Filings
2024-04-08 English
Next Day Disclosure Return
Regulatory Filings
2024-04-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Regulatory Filings
2024-04-02 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH USA INC. ENTERS INTO MASTER MANUFACTURING AND SUPPLY SERVICES AGREEMENT WITH NOVARTIS PHARMACEUTICALS CORPORATION
Regulatory Filings
2024-04-01 English
Next Day Disclosure Return
Regulatory Filings
2024-03-26 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PUBLICATION OF INAUGURAL ESG REPORT
Regulatory Filings
2024-03-19 English
OVERSEAS REGULATORY ANNOUNCEMENT: ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2024-03-19 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH CORPORATION ANNOUNCES POSITIVE OPINION FROM THE U.S. FDA ODAC FOR CARVYKTI FOR THE EARLIER TREATMENT OF PATIENT WITH RELAPSED/REFRACTORY MULTIPLE
Regulatory Filings
2024-03-17 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2024-03-13 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH CORPORATION RELEASES SPONSOR AND FDA BRIEFING BOOKS FOR CARVYKTI
Regulatory Filings
2024-03-13 English
OVERSEAS REGULATORY ANNOUNCEMENT: UNAUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND THE YEAR ENDED 31 DECEMBER 2023 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2024-03-11 English
Risk Management and ESG Committee - Terms of Reference
Regulatory Filings
2024-03-10 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Regulatory Filings
2024-03-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Regulatory Filings
2024-03-06 English
Notification Letter to Non-Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings
2024-03-01 English
Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings
2024-03-01 English
DATE OF BOARD MEETING
Regulatory Filings
2024-02-27 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES POSITIVE CHMP OPINION FOR CARVYKTI FOR THE TREATMENT OF PATIENTS WITH RELAPSED AND LENALIDOMIDE REFRACTORY MULTIPLE MYELOMA IN EARLIER LINES
Regulatory Filings
2024-02-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Regulatory Filings
2024-02-05 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES UPDATE ON U.S. FDA AND EMA APPLICATIONS FOR EXPANDED USE OF CARVYKTI AND U.S. FDA LABEL UPDATE FOR CAR-T CELL IMMUNOTHERAPIES
Regulatory Filings
2024-01-23 English
VOLUNTARY ANNOUNCEMENT: PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 31 DECEMBER 2023
Regulatory Filings
2024-01-23 English
VOLUNTARY ANNOUNCEMENT: PRESENTATIONS ON COMPANY UPDATES AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Regulatory Filings
2024-01-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Regulatory Filings
2024-01-05 English
VOLUNTARY ANNOUNCEMENT: CLOSING OF THE EXCLUSIVE GLOBAL LICENSING AGREEMENT BETWEEN LEGEND BIOTECH AND NOVARTIS
Regulatory Filings
2024-01-03 English